Alexander Douglas

Dr. Alexander (Sandy) Douglas is an Associate Professor in Vaccine Development at the Jenner Institute, University of Oxford. His work bridges protein biochemistry, virology, and clinical trials to advance antibody-inducing vaccines and low-cost biomanufacturing solutions.

• Specialties: Epstein-Barr Virus (EBV), Rabies, Malaria (PfRH5 antigen), and Bioprocess Development
• Led scale-up of Oxford-AstraZeneca COVID-19 vaccine
• Co-Investigator on EPSRC-funded Vax-Hub

His research focuses on overcoming translational barriers for novel biological medicines, particularly in resource-limited settings. Recent publications highlight innovations in adenovirus-vectored vaccines, malaria antigen screening, and cost-effective manufacturing.

Scientific Awards:

• Wellcome Trust Career Development Fellow
• Wellcome-Beit Prize winner

As leader of the Bioprocess and Analytical Development (BiPAD) team, he drives collaborations across the UK and internationally to streamline vaccine production. His work includes clinical trials for single-dose rabies vaccines (MRC DPFS-funded) and developing the first EBV vaccine targeting cancers and immune-mediated diseases.